Vivimed Labs Files SEBI Compliance Certificate for Q3 FY26
Vivimed Labs Limited filed a compliance certificate for the quarter ending December 31, 2025. The RTA confirmed adherence to SEBI regulations regarding securities dematerialization and record updates within the stipulated 15-day period.
This is a standard regulatory filing that is part of the company's ongoing compliance procedures. It does not introduce any new information that would significantly affect the company's operations, financials, or stock price.
The announcement is a routine compliance filing related to SEBI regulations and does not contain any material financial or business updates that would impact the company's sentiment.
Vivimed Labs Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended December 31, 2025. The company's Registrar and Share Transfer Agent (RTA), Aarthi Consultants Private Limited, has confirmed that all actions, including dematerialization of securities, cancellation of original certificates, and updating the depository as the registered owner, were completed within 15 days of receiving the certificates from depository participants.
The confirmation pertains to the period from October 1, 2025, to December 31, 2025. This filing ensures that the securities are in dematerialized form and listed on the stock exchanges as required by SEBI regulations. The company has requested that this information be taken on record.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.